 ImmuCell Corporation Nasdaq: ICCC ImmuCell or the Company, a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the health and productivity of dairy and beef calves, today announced receipt of a 500,000 subordinated loan from the Maine Technology Institute MTI, whose mission is to support Maines innovation economy. This loan supports the Companys investments to increase the production capacity of First Defense, to complete the development of Re-TainTM and to bring the formulation and aseptic filling services for Re-TainTM in-house after FDA approval and market launch. 